Subscribe to our Newsletter
Erasmus Medical Centre, located in Rotterdam, the Netherlands, is an international leading academic hospital with a mission for a healthy population and to pursue excellence in healthcare through research and teaching. Erasmus MC is a public organisation. In 2021 Erasmus MC had 659,317 outpatient visits. Erasmus MC posted a financial result of €46 million in 2021. Sustainability is visibly on the move at Erasmus MC and the subject is gaining broader support. For example, several Green Teams have been set up in the departments.
Hospital travel for blood sampling poses a significant burden on patients, often requiring assistance and contributing to substantial travel distances. The implemented home-based blood sampling solution addresses these burdens by providing patients with the flexibility to draw blood at their convenience, thus reducing productivity loss and eliminating unnecessary travel.
In-hospital blood sampling affects a wide range of patients, including those with chronic diseases, oncology patients, and individuals needing routine blood tests. Given the prevalence of chronic diseases, the implemented painless home-based blood sampling device addresses the need to significantly improve the healthcare experience for a substantial portion of the population.
The solution addresses the challenges associated with in-hospital blood sampling by providing a convenient and patient-centered alternative.
Furthermore, hospital visits for blood sampling negatively impact patients’ well-being, evoking distress and anxiety. By shifting the sampling process to patients’ homes, and allowing blood draws outside office hours, the solution addresses these issues by granting patients a sense of control and reducing hospital-related stress. This flexibility empowers patients to actively participate in their healthcare.
The implemented home-based alternative addresses the limitations of hospital-based sampling and improves blood sample collection. This effort is driven by the desire to enhance patient outcomes, improve well-being, increase convenience and patient involvement, and reduce the environmental impact of unnecessary travel.
Ailin is a diagnostics-as-a-service platform that enables the diagnosis and monitoring of key health parameters from home through self-sample kits and a cutting-edge diagnostic support platform.
The proposed solution addresses the challenges of lab test accessibility and seeks to improve patient experience. Specifically, it addresses the need for a pioneering blood extraction device, co-developed and co-created to set new standards in painless extraction, environmental impact, and large-volume blood retrieval. This innovative device addresses the optimization of the sampling process, minimizing errors and ensuring accuracy, thus improving patient satisfaction and facilitating an end-to-end diagnostics project.
Patients benefits as the device addresses their desire for convenient, flexible, and painless testing, transforming healthcare with superior outcomes. The device also addresses the integration of an at-home lab testing kit and results platform, forming a holistic diagnostic solution. Through this collaboration, the solution addresses the broader goal of improve healthcare, enhancing patient outcomes, and empowering self-care from home.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under the Grant Agreement 101071212.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
